AMB-CHMINACA
Chemical compound
From Wikipedia, the free encyclopedia
AMB-CHMINACA or MMB-CHMINACA (also known as MA-CHMINACA) is an indazole-based synthetic cannabinoid[1] that is a potent agonist of the CB1 receptor and has been sold online as a designer drug.[2][3][4]
Legal status
- CA: Schedule II
- DE: NpSG (Industrial and scientific use only)
- UK: Class B
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C21H29N3O3 |
| Molar mass | 371.481 g·mol−1 |
| 3D model (JSmol) | |
| |
| |